ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,730Medicare Part D Prescriptions Filled, Including Refills

Rank: 142 out of 2343

$846K Total Retail Price of All Prescriptions

Rank: 214 out of 2343

566 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 566 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

2% of this provider’s 566 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 15,897 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
AMLODIPINE BESYLATE 1,209 1,169 1 5
METFORMIN HCL 988 927 2 9
SIMVASTATIN 967 872 3 1
HYDROCHLOROTHIAZIDE 791 774 4 11
ATENOLOL 692 649 5 12
LISINOPRIL 566 562 6 3
ALENDRONATE SODIUM 515 485 7 28
GLIPIZIDE XL 407 369 8 84
EVISTA 383 383 9 128
ALLOPURINOL 304 292 10 31
OMEPRAZOLE 283 265 11 4
METOPROLOL TARTRATE 254 242 12 7
DIOVAN 245 240 13 23
RANITIDINE HCL 239 224 14 43
NIASPAN 236 212 15 141
GLIMEPIRIDE 217 217 16 45
AMLODIPINE BESYLATE-BENAZEPRIL 215 215 17 59
LEVOTHYROXINE SODIUM 213 193 18 2
ATORVASTATIN CALCIUM 211 203 19 10
DOXAZOSIN MESYLATE 205 205 20 98
LOSARTAN POTASSIUM 191 167 21 19
LOVASTATIN 190 190 22 47
DIOVAN HCT 182 151 23 63
LIDODERM 174 159 24 130
NAPROXEN 154 150 25 108
JANUVIA 150 140 26 50
TAMSULOSIN HCL 123 115 27 29
LISINOPRIL-HYDROCHLOROTHIAZIDE 121 119 28 42
CARVEDILOL 118 118 29 27
BETAMETHASONE VALERATE 118 116 29 341
ENALAPRIL MALEATE 116 103 31 58
GLYBURIDE-METFORMIN HCL 115 112 R 32 154
ONGLYZA 115 115 32 211
CRESTOR 113 113 34 30
FUROSEMIDE 106 106 35 6
ATENOLOL-CHLORTHALIDONE 103 103 36 190
LIPITOR 101 101 37 78
CELEBREX 97 91 38 71
TRICOR 88 83 39 96
PRAVASTATIN SODIUM 88 83 39 15
MECLIZINE HCL 87 85 41 103
BETAMETHASONE DIPROPIONATE 86 83 42 284
AVODART 85 85 43 165
NIFEDIAC CC 85 85 43 376
GLIPIZIDE ER 84 71 45 115
LOVAZA 82 72 46 113
DONEPEZIL HCL 77 77 47 21
CEPHALEXIN 75 68 48 111
ACTOS 73 61 49 125
GEMFIBROZIL 73 73 49 133
NASONEX 71 62 51 209
ZOLPIDEM TARTRATE 70 61 52 24
FEXOFENADINE HCL 68 64 53 240
METOPROLOL SUCCINATE 67 67 54 14
LOSARTAN-HYDROCHLOROTHIAZIDE 66 65 55 64
ISOSORBIDE MONONITRATE ER 65 65 56 32
IBUPROFEN 62 60 57 75
PROCTOZONE-HC 62 62 57 208
ZETIA 61 52 59 52
LIDOCAINE 59 59 60 258
NEXIUM 55 55 61 33
WARFARIN SODIUM 51 51 62 8
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 19, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.